RT Journal Article
T1 Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis.
A1 García-Ceberino, Pedro M
A1 Faro-Míguez, Naya
A1 Beltrán-Ávila, Francisco Javier
A1 Fernández-Reyes, Daniel
A1 Gallardo-Muñoz, Inmaculada
A1 Guirao-Arrabal, Emilio
K1 COVID-19
K1 Deep vein thrombosis
K1 Ecografía
K1 Embolia pulmonar
K1 Heparina de bajo peso molecular
K1 Low-molecular-weight heparin
K1 Pulmonary embolism
K1 Trombosis venosa profunda
K1 Ultrasonography
AB Deep vein thrombosis (DVT) and pulmonary embolism (PE) are both complications linked with COVID-19. Lower limb point-of-care clinical ultrasound (POCUS) could detect occult clots, helping decide whom to treat with anticoagulation. To determine proximal DVT prevalence with POCUS screening among hospitalized COVID-19 patients. Lower limb POCUS was performed in all patients admitted either to the ward or intensive care unit (ICU) between April 22nd and 30th 2020. Clinical and laboratory features, prescriptions, thrombotic complications and outcomes were assessed. 87 patients were screened, of which 26 (29.8%) either had been discharged from ICU (19.5%) or were still in critical condition (10.3%). DVT was found in 4 patients (3 femoral, 1 popliteal), of which 1 had not received low molecular weight heparin (LMWH) prophylaxis. 21 CT pulmonary angiograms were performed, being positive for PE in 5 cases (23.8%); only 2 of these patients suffered DVT. Screening lower extremities with POCUS did not find a high rate of DVT among patients receiving LMWH-prophylaxis. However, there was a noteworthy amount of PE without DVT.
YR 2021
FD 2021-02-27
LK https://hdl.handle.net/10668/26027
UL https://hdl.handle.net/10668/26027
LA en
LA es
DS RISalud
RD Apr 17, 2025